Mark Your Calendar to Join Us Next Year September 23-26, 2024|Hynes Convention Center in Boston, Boston, MA
The Cell and Gene Therapy Event for Ground-Breaking Manufacturing, Commercialization and Supply Chain Strategies
World renowned leaders share the latest bioprocessing science and technologies to improve manufacturing scalability, cost, and quality to increase access to patients in rare diseases and beyond
3000+ Global Attendees · 250+ Exhibitors · 180+ Scientific Posters · 8 Conference Tracks
Thank You to the 3000+ Attendees of CGT US 2023!
This year's event was the largest in event history, gathering 3000+ attendees and 260+ exhibitors representing 40 countries around the world. Mark your calendar to join us at next year's event, held September 23-26, 2024 at the Hynes Convention Center in Boston. Sign up for email updates below for the latest news on CGT US 2024 events.
Get the Latest Event Updates
Bringing you cutting edge case studies to improve efficiencies in cell and gene therapy production
Below are the main topics of the Cell & Gene Therapy Manufacturing & Commercialization 2023 event.
Cell Therapy Manufacturing
Improve process productivity, analytical characterization and reduce cost of goods in autologous cell therapy manufacturing with case study insights from Novartis, Vertex, BMS and Triumvira Immunologics Inc.
Gene Edited Ex Vivo Cell Therapy Manufacturing
Overcome scale up and manufacturing challenges in the development and commercialization of next generation “off the shelf” and gene edited products including CAR-Ts, NK cells, TCRs, TILs and iPSCs
In Vivo Gene Therapy Manufacturing
Increase speed, consistency, scalability, and flexibility in your gene therapy manufacturing with case studies from leading gene therapy companies with approved products including Spark Therapeutics, PTC Therapeutics and bluebird bio.
New for 2023! Supply Chain, Cryopreservation & Logistics
GSK, BMS, ElevateBio, Gamida Cell Inc. and Precision Biosciences, Inc share best practises to mitigate risk for seamless end to end supply chains and reliable distribution of CGT products
New for 2023! Well Characterized Biologics & Biological Assays
Gain practical advice from FDA, US Pharmacopeia, National Institute of Standards and Technology and industry case studies on analytical method development, characterization and validation standards for biologics and novel modalities
Co-located with the BPI International Conference & Expo
Benefit from a conference pass including access to all talks and networking opportunities for 8 conference tracks covering novel science across all phases of bioprocessing for biologics and cell & gene therapies
100+ Cell and Gene Therapy Thought Leaders Including
Over 100 top scientists from the industry will be sharing the latest updates on how to improve efficiencies across all phases of Cell & Gene Therapy development and production at CGT US 2023.
Here's a sneak peek at some of our key speakers who will be presenting on the agenda:
Pass options
Discover the perfect in-person pass for your needs, each with its own exclusive benefits. Explore our selection of pass types below.
For Digital Pass information, please click here.
Get a Sneak Peek of CGT US
See what's in store for the cell & gene therapy event for ground-breaking manufacturing, commercialization, and supply chain strategies!
CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2023
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Perri Lucatello: PLucatello@informaconnectls.com | +44 208 052 0465
